Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Free Report) was the recipient of a large decline in short interest in December. As of December 15th, there was short interest totalling 25,800 shares, a decline of 37.4% from the November 30th total of 41,200 shares. Based on an average trading volume of 96,300 shares, the short-interest ratio […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Free Report) – Stock analysts at Brookline Capital Management decreased their FY2023 earnings per share (EPS) estimates for Adial Pharmaceuticals in a research note issued on Tuesday, November 14th. Brookline Capital Management analyst K. Dolliver now expects that the company will earn ($5.46) per share for the year, down from […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Free Report) saw a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 50,800 shares, an increase of 49.4% from the September 15th total of 34,000 shares. Currently, 4.8% of the shares of the company are sold short. Based […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) was the recipient of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 324,800 shares, a decline of 22.0% from the April 30th total of 416,400 shares. Based on an average daily volume of 671,600 shares, the […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) – Equities research analysts at Litchfield Hills Research upped their Q2 2023 earnings per share estimates for Adial Pharmaceuticals in a report released on Thursday, May 18th. Litchfield Hills Research analyst T. O’neill now expects that the company will post earnings of ($0.09) per share for the quarter, […]